Literature DB >> 30011411

Autoimmune Dementia.

Justin M Long1, Gregory S Day1,2.   

Abstract

Dementia refers to an acquired syndrome of intraindividual cognitive decline that ultimately interferes with an individual's ability to manage their usual duties at work or home. As experience with the diagnosis and management of patients with autoimmune and paraneoplastic encephalitis (AE) has expanded, it has become increasingly apparent that dementia may arise as a subacute or chronic complication of immune-mediated injury to the central nervous system. Progressive memory and thinking problems may represent the first (or only) sign of an underlying autoimmune or paraneoplastic disease. Accordingly, there is a need to routinely consider the diagnosis of AE in patients with dementia, and to evaluate patients recovering from AE for clinically meaningful cognitive impairment. We review and summarize the available evidence concerning the diagnosis and care of AE patients with associated cognitive impairment, herein referred to as autoimmune dementia (AiD). Relevant information is used to propose a novel diagnostic framework that may be applied to improve recognition, and facilitate the expedited evaluation and treatment of patients with AiD. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2018        PMID: 30011411     DOI: 10.1055/s-0038-1660480

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  12 in total

1.  Sleep disturbances are common in patients with autoimmune encephalitis.

Authors:  Margaret S Blattner; Gabriela S de Bruin; Robert C Bucelli; Gregory S Day
Journal:  J Neurol       Date:  2019-02-11       Impact factor: 4.849

2.  A Neurologist's Practical Approach to Cognitive Impairment.

Authors:  Philip W Tipton; Gregory S Day; Neill Graff-Radford
Journal:  Semin Neurol       Date:  2021-11-26       Impact factor: 3.420

Review 3.  Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients.

Authors:  Pierpaolo Turcano; Gregory S Day
Journal:  Curr Opin Neurol       Date:  2022-06-01       Impact factor: 6.283

Review 4.  Rapidly Progressive Dementia.

Authors:  Gregory S Day
Journal:  Continuum (Minneap Minn)       Date:  2022-06-01

5.  Rapidly Progressive Dementia in the Outpatient Clinic: More Than Prions.

Authors:  Gregory S Day; Erik S Musiek; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

Review 6.  Sleep Disturbances in Patients with Autoimmune Encephalitis.

Authors:  Margaret S Blattner; Gregory S Day
Journal:  Curr Neurol Neurosci Rep       Date:  2020-06-10       Impact factor: 5.081

7.  Leveraging molecular biomarkers to make the common diagnosis in the uncommon patient.

Authors:  Gregory S Day; Brian A Gordon; Robert C Bucelli; Richard J Perrin; A Sebastian Lopez-Chiriboga; Beau M Ances
Journal:  J Neuroimmunol       Date:  2021-01-07       Impact factor: 3.478

8.  The sum of us. Implementing a Person Centred Care Bundle - A narrative inquiry.

Authors:  Ruth Harper; Louise Ward; Kate Silburn
Journal:  Appl Nurs Res       Date:  2020-05-03       Impact factor: 2.257

9.  Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.

Authors:  Gregory S Day; Melanie Y Yarbrough; Peter Körtvelyessy; Harald Prüss; Robert C Bucelli; Marvin J Fritzler; Warren Mason; David F Tang-Wai; Claude Steriade; Julien Hébert; Rachel L Henson; Elizabeth M Herries; Jack H Ladenson; A Sebastian Lopez-Chiriboga; Neill R Graff-Radford; John C Morris; Anne Fagan
Journal:  Neurology       Date:  2021-04-01       Impact factor: 9.910

10.  The Road to Recovery: A Pilot Study of Driving Behaviors Following Antibody-Mediated Encephalitis.

Authors:  Gregory S Day; Ganesh M Babulal; Ganesh Rajasekar; Sarah Stout; Catherine M Roe
Journal:  Front Neurol       Date:  2020-07-28       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.